Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus
about
Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odysseyLysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristin-dalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulInfluence of platelets and platelet microbicidal protein susceptibility on the fate of Staphylococcus aureus in an in vitro model of infective endocarditis.Comparison of antimicrobial agents as therapy for experimental endocarditis: caused by methicillin-resistant Staphylococcus aureus.Oral antibiotic therapy for the treatment of infective endocarditis: a systematic reviewEfficacy of vancomycin and teicoplanin alone and in combination with streptomycin in experimental, low-level vancomycin-resistant, VanB-type Enterococcus faecalis endocarditisMethicillin resistance in staphylococci: molecular and biochemical basis and clinical implications.Community-associated methicillin-resistant Staphylococcus aureus: a review.Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus.Antimicrobial agents for treatment of serious infections caused by resistant Staphylococcus aureus and enterococci.Invasive community-associated MRSA infections: epidemiology and antimicrobial management.Similarities and differences between doxycycline and minocycline: clinical and antimicrobial stewardship considerations.Pharmacodynamics of minocycline against Staphylococcus aureus in an in vitro pharmacokinetic model.New uses for older antibiotics. The 'rediscovery' of four beneficial and cost-effective antimicrobials.Rapid decrease of free vancomycin in dense staphylococcal cultures.
P2860
Q28235095-3B16CB5A-D42F-4D2C-8669-727BA9E7FEABQ28379547-A2D3D23D-63E5-4394-B1FB-2B00F1152881Q33700022-E9AAC226-057B-4B7B-A4AC-5DBC383D2863Q34007865-2F4FD633-20EE-4D7F-A67E-18D52291F4CDQ34090666-42FD866F-D77D-4ECC-A957-31A60D1F1307Q35119494-6F9725B7-F8A7-4EBD-BCB5-2637A1E79ABDQ35121434-B92094C0-3806-406D-A010-E4E2FAB8D80AQ35376362-AE9D4BED-710D-4130-A295-A0098F2E7E1AQ36070903-A0BD72FE-46BF-4B50-8193-759C9EBE3FB5Q36094861-A0CF6B0E-EE66-4F66-AF70-CDF1728D5F85Q36325685-F89E573C-972C-4D51-B020-A0B1249F871DQ37800939-FEEA54E6-E11E-4B6C-A5EC-DEEBF00E5B27Q40088726-756FECB9-2BB3-4BC3-90C8-FD5BDE7ADA86Q41387743-2B0070CF-6551-4C9F-9249-381E6CDD9FD5Q41450767-7100AD3A-BC7D-4370-9EB1-E3144CB0DF53Q46723031-88766E3C-BE51-4E21-A1CB-9050201B564F
P2860
Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus
description
1994 nî lūn-bûn
@nan
1994 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Minocycline versus vancomycin ...... esistant Staphylococcus aureus
@ast
Minocycline versus vancomycin ...... esistant Staphylococcus aureus
@en
type
label
Minocycline versus vancomycin ...... esistant Staphylococcus aureus
@ast
Minocycline versus vancomycin ...... esistant Staphylococcus aureus
@en
prefLabel
Minocycline versus vancomycin ...... esistant Staphylococcus aureus
@ast
Minocycline versus vancomycin ...... esistant Staphylococcus aureus
@en
P2093
P2860
P356
P1476
Minocycline versus vancomycin ...... esistant Staphylococcus aureus
@en
P2093
Freeman CD
Nicolau DP
Nightingale CH
Quintiliani R
P2860
P304
P356
10.1128/AAC.38.7.1515
P407
P577
1994-07-01T00:00:00Z